CLOSED - Clinical Trial on Vaccine $65

Clinical Trial on Vaccine

Description

Respiratory Syncytial Virus (RSV), is a virus that can cause respiratory tract infections. It is also the most common cause of bronchitis and pneumonia in young children and older adults. Synexus US is seeking adult volunteers in good or stable health to evaluate the safety and efficacy of an RSV vaccination. You may be eligible to participate in this study if you: are 65 years of age or older; are in good or stable health (any underlying illnesses are stable, medically controlled, and only interfere only somewhat with usual daily activities. Eligible participants may receive study-related care and study vaccine (or placebo) at no cost, and may be compensated for study-related time and travel. If you are interested in participating, please sign up and volunteer today: www.RSVResearch.com
Published: 09/06/2019
Payout: $65
Gender: Multiple
Age Range: 65+
Company: N/A
Cities / States:
Expires: 10/01/2019

Other focus groups: